1.
A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes
by Magdalinou, N K
Journal of neurology, neurosurgery and psychiatry, 2015, Vol.86 (11), p.1240-1247
2.
Fifty years of progressive supranuclear palsy
by Colosimo, Carlo
Journal of neurology, neurosurgery and psychiatry, 2014, Vol.85 (8), p.938-944
3.
Divergent CSF τ alterations in two common tauopathies: Alzheimer's disease and progressive supranuclear palsy
by Wagshal, Dana
Journal of neurology, neurosurgery and psychiatry, 2015, Vol.86 (3), p.244-250
4.
Lewy body dementias
by Walker, Zuzana, Dr
The Lancet (British edition), 2015, Vol.386 (10004), p.1683-1697
5.
The Addenbrooke's Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders
by Rittman, Timothy
Journal of neurology, neurosurgery and psychiatry, 2013, Vol.84 (5), p.544-551
6.
Validation of the new consensus criteria for the diagnosis of corticobasal degeneration
by Alexander, S K
Journal of neurology, neurosurgery and psychiatry, 2014, Vol.85 (8), p.925-929
7.
Survival in progressive supranuclear palsy and frontotemporal dementia
by Chiu, Wang Zheng
Journal of neurology, neurosurgery and psychiatry, 2010, Vol.81 (4), p.441-445
8.
An algorithmic approach to structural imaging in dementia
by Harper, Lorna
Journal of Neurology, Neurosurgery and Psychiatry, 2014, Vol.85 (6), p.692-698
9.
Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study
by Schrag, A
The Lancet (British edition), 1999, Vol.354 (9192), p.1771-1775
10.
Validation of the Italian version of the PSP Quality of Life questionnaire
by Picillo, Marina
Neurological sciences, 2019, Vol.40 (12), p.2587-2594
11.
Progressive supra-nuclear palsy: frequency of cardinal extrapyramidal features at first presentation
by Pradhan, Sunil
Postgraduate medical journal, 2015, Vol.91 (1075), p.274-277
12.
Vertical supranuclear gaze palsy in Niemann-Pick type C disease
by Salsano, Ettore
Neurological sciences, 2012, Vol.33 (6), p.1225-1232
13.
Gray matter atrophy in progressive supranuclear palsy: meta-analysis of voxel-based morphometry studies
by Shi, Hai Cun
Neurological sciences, 2013, Vol.34 (7), p.1049-1055
14.
Using the presence of visual hallucinations to differentiate Parkinson’s disease from atypical parkinsonism
by Williams, D R
Journal of neurology, neurosurgery and psychiatry, 2008, Vol.79 (6), p.652-655
15.
The Impact of MRI White Matter Hyperintensities on Dementia in Parkinson's Disease in Relation to the Homocysteine Level and Other Vascular Risk Factors
by Sławek, Jarosław
Neuro-degenerative diseases, 2013, Vol.12 (1), p.1-12
16.
Midbrain-to-pons ratio in autopsy-confirmed progressive supranuclear palsy: replication in an independent cohort
by Kaasinen, Valtteri
Neurological sciences, 2015, Vol.36 (7), p.1251-1253
17.
Applause sign: is it really specific for Parkinsonian disorders? Evidence from cortical dementias
by Luzzi, S
Journal of neurology, neurosurgery and psychiatry, 2011, Vol.82 (8), p.830-833
18.
Progressive supranuclear palsy finally has a clinically measureable τ abnormality
by Halliday, Glenda
Journal of neurology, neurosurgery and psychiatry, 2015, Vol.86 (3), p.241-241
19.
Occurrence of the “applause sign” in patients with amyotrophic lateral sclerosis
by Anneser, Johanna M.H
Clinical neurology and neurosurgery, 2015, Vol.137, p.8-10
20.
Cerebellar dentate nucleus in progressive supranuclear palsy
by Sawa, Nobuhiro
Clinical neurology and neurosurgery, 2014, Vol.118, p.32-36
